BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Choi C, Yoo GS, Cho WK, Park HC. Optimizing radiotherapy with immune checkpoint blockade in hepatocellular carcinoma. World J Gastroenterol 2019; 25(20): 2416-2429 [PMID: 31171886 DOI: 10.3748/wjg.v25.i20.2416]
URL: https://www.wjgnet.com/1007-9327/full/v25/i20/2416.htm
Number Citing Articles
1
David Tai, Su Pin Choo, Valerie Chew. Rationale of Immunotherapy in Hepatocellular Carcinoma and Its Potential BiomarkersCancers 2019; 11(12): 1926 doi: 10.3390/cancers11121926
2
Jin Hee Park, Hee Yeon Kim, Anbok Lee, Young Kyeong Seo, Il-Hwan Kim, Eun-tae Park, Mi Seon Kang, Sung Jae Park, SaeGwang Park. Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1International Journal of Radiation Oncology*Biology*Physics 2021; 110(2): 510 doi: 10.1016/j.ijrobp.2020.12.031
3
Sunmin Park, Won Sup Yoon, Mi Hee Jang, Chai Hong Rim. Clinical efficacy of external beam radiotherapy complementing incomplete transarterial chemoembolization for hepatocellular carcinomaInternational Journal of Radiation Biology 2020; 96(12): 1541 doi: 10.1080/09553002.2020.1830316
4
Ann-Lii Cheng, Chiun Hsu, Stephen L. Chan, Su-Pin Choo, Masatoshi Kudo. Challenges of combination therapy with immune checkpoint inhibitors for hepatocellular carcinomaJournal of Hepatology 2020; 72(2): 307 doi: 10.1016/j.jhep.2019.09.025
5
Han Ah Lee, Sunmin Park, Yeon Seok Seo, Won Sup Yoon, In‐Soo Shin, Chai Hong Rim. Surgery versus external beam radiotherapy for hepatocellular carcinoma involving the inferior vena cava or right atrium: A systematic review and meta‐analysisJournal of Hepato-Biliary-Pancreatic Sciences 2020;  doi: 10.1002/jhbp.865
6
Sung-Won Shin, Kyungmi Yang, Miso Lee, Jiyoung Moon, Arang Son, Yeeun Kim, Suha Choi, Do-hyung Kim, Changhoon Choi, Nohyun Lee, Hee Chul Park. Manganese Ferrite Nanoparticles Enhance the Sensitivity of Hepa1-6 Hepatocellular Carcinoma to Radiation by Remodeling Tumor MicroenvironmentsInternational Journal of Molecular Sciences 2021; 22(5): 2637 doi: 10.3390/ijms22052637
7
Luis A. Pérez-Romasanta, Elisabet González-Del Portillo, Ana Rodríguez-Gutiérrez, Ángela Matías-Pérez. Stereotactic Radiotherapy for Hepatocellular Carcinoma, Radiosensitization Strategies and Radiation-Immunotherapy CombinationCancers 2021; 13(2): 192 doi: 10.3390/cancers13020192
8
Vincenzo Quagliariello, Margherita Passariello, Domenica Rea, Antonio Barbieri, Martina Iovine, Annamaria Bonelli, Antonietta Caronna, Gerardo Botti, Claudia De Lorenzo, Nicola Maurea. Evidences of CTLA-4 and PD-1 Blocking Agents-Induced Cardiotoxicity in Cellular and Preclinical ModelsJournal of Personalized Medicine 2020; 10(4): 179 doi: 10.3390/jpm10040179
9
Kyoung‐Jin Kim, Hye Won Lee, Jinsil Seong. Combination therapy with anti‐T‐cell immunoglobulin and mucin‐domain containing molecule 3 and radiation improves antitumor efficacy in murine hepatocellular carcinomaJournal of Gastroenterology and Hepatology 2021; 36(5): 1357 doi: 10.1111/jgh.15319
10
Wenzhe Yin, Jun Xu, Chao Li, Xiankui Dai, Tong Wu, Jifeng Wen. Plantamajoside inhibits the proliferation and epithelial‐to‐mesenchymal transition in hepatocellular carcinoma cells via modulating hypoxia‐inducible factor‐1α‐dependent gene expressionCell Biology International 2020; 44(8): 1616 doi: 10.1002/cbin.11354
11
Thomas Helmberger. The evolution of interventional oncology in the 21st centuryThe British Journal of Radiology 2020; 93(1113): 20200112 doi: 10.1259/bjr.20200112
12
Changhoon Choi, Yeonwoo Cho, Arang Son, Sung-Won Shin, Yeon-Ju Lee, Hee Chul Park. Therapeutic Potential of (−)-Agelamide D, a Diterpene Alkaloid from the Marine Sponge Agelas sp., as a Natural Radiosensitizer in Hepatocellular Carcinoma ModelsMarine Drugs 2020; 18(10): 500 doi: 10.3390/md18100500
13
Hye Won Lee, Kyung Joo Cho, Jun Yong Park. Current Status and Future Direction of Immunotherapy in Hepatocellular Carcinoma: What Do the Data Suggest?Immune Network 2020; 20(1) doi: 10.4110/in.2020.20.e11
14
Magalie Dosset, Elodie Lauret-Marie Joseph, Thaiz Rivera Vargas, Lionel Apetoh. Modulation of Determinant Factors to Improve Therapeutic Combinations with Immune Checkpoint InhibitorsCells 2020; 9(7): 1727 doi: 10.3390/cells9071727
15
Han Ah Lee, Chai Hong Rim. Efficacy of Local Treatments for Hepatocellular Carcinoma Involving the Inferior Vena Cava and/or Right AtriumJournal of Hepatocellular Carcinoma 2020; : 435 doi: 10.2147/JHC.S285357
16
Nalee Kim, Jeong Il Yu, Hee Chul Park, Gyu Sang Yoo, Changhoon Choi, Jung Yong Hong, Ho Yeong Lim, Jeeyun Lee, Moon Seok Choi, Jung Eun Lee, Kyunga Kim. Incorporating sarcopenia and inflammation with radiation therapy in patients with hepatocellular carcinoma treated with nivolumabCancer Immunology, Immunotherapy 2021; 70(6): 1593 doi: 10.1007/s00262-020-02794-3
17
Chai Hong Rim, Hye Yoon Lee, Jung Sun Kim, Hakyoung Kim. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?International Journal of Radiation Biology 2021; 97(2): 111 doi: 10.1080/09553002.2021.1857453
18
Heather Nesbitt, Keiran Logan, Keith Thomas, Bridgeen Callan, Jinhui Gao, Thomas McKaig, Mark Taylor, Mark Love, Eleanor Stride, Anthony P. McHale, John F. Callan. Sonodynamic therapy complements PD-L1 immune checkpoint inhibition in a murine model of pancreatic cancerCancer Letters 2021; 517: 88 doi: 10.1016/j.canlet.2021.06.003
19
Liang-Cheng Chen, Hon-Yi Lin, Shih-Kai Hung, Wen-Yen Chiou, Moon-Sing Lee. Role of modern radiotherapy in managing patients with hepatocellular carcinomaWorld Journal of Gastroenterology 2021; 27(20): 2434-2457 doi: 10.3748/wjg.v27.i20.2434
20
Yvonne Chiung-Fang Hsu, Jason Chia-Hsien Cheng. Radiotherapy of Liver Cancer2021; : 325 doi: 10.1007/978-981-16-1815-4_23
21
Hailong Sheng, Yan Huang, Yazhi Xiao, Zhenru Zhu, Mengying Shen, Peitao Zhou, Zeqin Guo, Jian Wang, Hui Wang, Wencong Dai, Wanjun Zhang, Jingyuan Sun, Chuanhui Cao. ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinomaJournal for ImmunoTherapy of Cancer 2020; 8(1): e000340 doi: 10.1136/jitc-2019-000340
22
Jun Won Kim, Ik Jae Lee. Exploring the mythical abscopal effect: Radiation and programmed cell death protein 1 (PD-1) blockade for hepatocellular carcinomaClinical and Molecular Hepatology 2021; 27(1): 103 doi: 10.3350/cmh.2020.0297
23
Yifei Dai, Weijie Qiang, Kequan Lin, Yu Gui, Xun Lan, Dong Wang. An immune-related gene signature for predicting survival and immunotherapy efficacy in hepatocellular carcinomaCancer Immunology, Immunotherapy 2021; 70(4): 967 doi: 10.1007/s00262-020-02743-0
24
Gyu Sang Yoo, Won-Gyun Ahn, Shin-Yeong Kim, Wonseok Kang, Changhoon Choi, Hee Chul Park. Radiation-induced abscopal effect and its enhancement by programmed cell death 1 blockade in the hepatocellular carcinoma: A murine model studyClinical and Molecular Hepatology 2021; 27(1): 144 doi: 10.3350/cmh.2020.0095
25
Edo Kon, Itai Benhar. Immune checkpoint inhibitor combinations: Current efforts and important aspects for successDrug Resistance Updates 2019; 45: 13 doi: 10.1016/j.drup.2019.07.004
26
Li-Bin Xu, Zhen-Guo Zhao, Song-Feng Xu, Xin-Xin Zhang, Ting Liu, Chang-You Jing, Shu-Guang Zhang, Sheng-Ji Yu. The landscape of gene mutations and clinical significance of tumor mutation burden in patients with soft tissue sarcoma who underwent surgical resection and received conventional adjuvant therapyThe International Journal of Biological Markers 2020; 35(3): 14 doi: 10.1177/1724600820925095